Trial Profile
A Study of a Topical Formulation of Nitroglycerin, Vascana® (MQX-503), and Matching Vehicle in the Treatment and Prevention of Symptoms Associated With Raynaud's Phenomenon
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 08 Dec 2014
Price :
$35
*
At a glance
- Drugs Nitroglycerin (Primary)
- Indications Raynaud's disease
- Focus Therapeutic Use
- Sponsors MediQuest Therapeutics
- 08 Dec 2014 New trial record